FARMINGTON, Conn. (PRWEB)
November 02, 2021

Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, was recently awarded a new patent by the United States Patent and Trademark Office for “Methods for Cell Lysis and Preparation of High Molecular Weight DNA from Modified Cells.”

U.S. Patent 11,149,246 B2 was awarded on October 19, 2021.

The patent outlines the method and materials for the lysis of modified eukaryotic cells. This method, which is used in the Shoreline Biome Rapid Prep Kits, provides researchers with a set of reagents to quickly and inexpensively generate high molecular weight single-stranded DNA ideal for the generation of long PCR fragments. The process is ideal for screening modified cells by a technique such as CRISPR to identify cells that have been successfully modified.

This patent builds upon Shoreline Biome’s intellectual property protection and expands its utility beyond bacteria.

“The rapid lysis method works so well for our microbiome customers that we wanted to extend the utility of our kits and methods to other areas of science where there are large sets of modified cells that need to be screened,” said Mark Driscoll, Ph.D., Shoreline Biome’s Co-Founder and Chief Science Officer. “An additional benefit of the method in this patent is that it works well with a small number of input cells. This makes it ideal for screening purposes because the low number of input cells means the clones can be grown with fewer rounds, which translates into a quicker turnaround time and lower cost.”

The lysis is performed on standard laboratory equipment (i.e., a thermal cycler) and is completed in a few minutes. Shoreline Biome sells the reagents used in this method in 16-well and 96-well plate formats.

To learn more, visit shorelinebiome.com.

About Shoreline Biome:

Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.

Share article on social media or email:

Hear first-hand from a patient on how early detection can improve outcomes for patients and their families.

TORONTO (PRWEB)
November 02, 2021

One in three adults in the US have risk factors for developing CKD, a gradual loss of kidney function that affects an estimated 37 million adults in the US, of which an estimated 90 percent are unaware of their condition. Labcorp researchers partnered with the National Kidney Foundation (NKF) to review laboratory-ordered tests and found that 4/5 US adults at risk for developing CKD, namely, those with diabetes and/or high blood pressure, are not undergoing guideline-recommended screening for CKD.

In this webinar, leaders from Labcorp and NKF will explore additional results from the Diabetes Care study. You’ll gain insights into NKF-American Society of Nephrology Task Force final report recommendations on reassessing the inclusion of race in diagnosing CKD, in particular the new race free eGFR. Additionally, you’ll learn about recently introduced HEDIS measure and efforts from NKF to improve CKD detection rates. Finally, you’ll hear first-hand from a patient on how early detection can improve outcomes for patients and their families.

Join expert speakers from Labcorp, Barbara S. Gillespie, MD, MMS, FASN, Vice President & Therapeutic Head of Nephrology, Adjunct Professor, University of North Carolina; and Jennifer Ennis, MD, Medical Director, as well as Joe Vassalotti, MD, Chief Medical Officer, National Kidney Foundation and Clinical Professor of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai; and Derek Forfang, Co-Chair of the National Forum of ESRD Networks’ Kidney Patient Advisory Council (KPAC), in a live webinar on Thursday, November 18, 2021 at 5:30pm EST (2:30pm PST).

For more information, or to register for this event, visit Addressing Low Detection of Chronic Kidney Disease in At-Risk Patients.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Massachusetts-based, digital cardiac health company InfoBionic has been awarded a contract with the Veterans Health Administration (VHA) to provide remote cardiac monitoring and diagnostic services.

We are the first company to deliver to the VA 4-in-1 remote cardiac arrythmia monitors which provide full disclosure and we couldn’t be prouder. Taking care of our nation’s veterans is more than our duty, it is our honor.

WALTHAM, Mass. (PRWEB)
November 02, 2021

Massachusetts-based, digital cardiac health company InfoBionic has been awarded a contract with the Veterans Health Administration (VHA) to provide remote cardiac monitoring and diagnostic services for the largest integrated health care system in the United States.

The VHA provides care to the nation’s military veterans at 1,293 healthcare facilities, which includes 171 Veterans Affairs medical centers and 1,112 out-patient sites. There are currently more than 9 million veterans enrolled in the VHA healthcare system.

“We are the first company to deliver to the VA 4-in-1 remote cardiac arrythmia monitors which provide full disclosure and we couldn’t be prouder. Taking care of our nation’s veterans is more than our duty, it is our honor. And we look forward to this relationship,” said Dave MacCutcheon, InfoBionic COO.

InfoBionic is the developer of the MoMe® Kardia platform, a simple-to-use, easy-to-wear remote cardiac monitoring and diagnostic device. “MoMe® Kardia is the only full disclosure ambulatory cardiac monitoring system in the United States that gives clinicians access to 24-hour echocardiogram (ECG) data for analysis any time during monitoring”, added MacCutcheon.

The VHA employs more than 367,200 full-time health care professionals and support staff. It is the nation’s largest provider of graduate medical education and a major contributor to medical and scientific research. More than 46,000 active volunteers, 120,000 health profession trainees, and nearly 16,000 affiliated medical faculty serve integral roles in the VHA community.

InfoBionic products are available to all federal buyers through the GSA Advantage program under contract 36F797721D0248.

About InfoBionic:

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks hindering faster, more effective diagnosis and decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic.

Share article on social media or email:

Oakland Zoo was alerted of the injured pelican who was suffering from a fishhook wound

Untold numbers of birds, turtles and other wildlife are affected by this solvable issue. Proper disposal of fishing line is crucial, and every citizen can help by picking up any fishing items found in nature

OAKLAND, Calif. (PRWEB)
November 02, 2021

On October 27th, Oakland Zoo received and responded to a call from distressed citizens visiting Lake Merritt, reporting a pelican suffering from a large fishhook lodged into its throat as well as fishing line encircling its neck and bill. The improperly disposed of fishing gear had been preventing the animal from being able to eat or drink for weeks.

Using two kayaks and a small motorboat to reach and then capture the pelican, Oakland Zoo’s VP of Animal Care, Colleen Kinzley, and Zoological Managers Ann Marie Bisagno and Andrea Dougall, then transported the bird to Oakland Zoo’s Veterinary Hospital for treatment.

Upon arrival at the Zoo, veterinary staff examined the bird, administered fluids, conducted a blood draw, and examined the injured area on the neck. From initial observations, the veterinary staff determined the pelican suffered from dehydration, starvation, and based on the bloodwork appeared to have possible anemia.

After examinations, Dr. Alex Herman, VP of Veterinary Service sat Oakland Zoo removed the one-inch barbed fishing hook from the pelican’s neck.

The pelican has now been aptly nicknamed ‘Merritt’ by Oakland Zoo staff.

Veterinary staff have successfully fed Merritt smelt and capelin fish, which is a hopeful sign of recovery. For now, Merritt will remain at Oakland Zoo’s Veterinary Hospital for ongoing wound treatment and recovery.

Many coastal birds and other marine life are injured or killed each year by cut and discarded fishing lines, associated hooks, and tackle.

“Untold numbers of birds, turtles and other wildlife are affected by this solvable issue. Proper disposal of fishing line is crucial, and every citizen can help by picking up any fishing items found in nature”, says Amy Gotliffe, Vice President of Conservation at Oakland Zoo.

These items are improperly disposed of on beaches or from fishing boats. The wildlife either becomes entangled in the fishing lines or experiences debilitating injuries. Between 2002 and 2015, a study by the Audubon Society reports that California-based International Bird Rescue treated at least 2,957 birds for injuries caused by fishing gear.

Oakland Zoo urges guests and the public to join them in Taking Action for Wildlife by changing fishing habits to help save birds and other marine life like ‘Merritt’ the pelican.

When fishing, never leave behind lures, hooks, fishing lines, or bait. Dispose of any gear properly in box or similar enclosed receptacle within designated disposal areas or at home.

Oakland Zoo is normally contacted by wildlife organizations to rescue animals. This is a rare occurrence for the Zoo to answer a public call. If you encounter injured wildlife, please call your local animal control center.

Contact:

Isabella Linares

Oakland Zoo

ilinares@oaklandzoo.org

Office: 510-632-9525 ext. 239

Erin Harrison

Oakland Zoo

eharrison@oaklandzoo.org

Office: 510-632-9525 ext. 120

ABOUT OAKLAND ZOO AND THE CONSERVATION SOCIETY OF CALIFORNIA:

Oakland Zoo, home to more than 850native and exotic animals, is managed by the Conservation Society of California(CSC); a non-profit organization leading an informed and inspired community in Taking Action for Wildlife locally and globally. With over 25 conservation partners and projects worldwide, the CSC is committed to conservation-based education and saving species and their habitats in the wild. Oakland Zoo is dedicated to the humane treatment of animals and is accredited by the Association of Zoos and Aquariums (AZA), the national organization that sets the highest standards for animal welfare for zoos and aquariums.

‍

Share article on social media or email:

“Bastion Health provides an accessible and affordable way for men to proactively take care of their health from the comfort of home and start normalizing the conversation surrounding men’s health, ” says Reza Amin, CEO and founder of Bastion Health.

NEW YORK (PRWEB)
November 02, 2021

Bastion Health, the first-ever comprehensive app-based telehealth platform for men’s health launches, specializing in reproductive and prostate health, providing quick and convenient access to urologists and men’s health specialists. Bastion aims to normalize the conversation surrounding men’s health and offers a way for men to proactively take control of their health from the comfort of their own home with convenient consultations, diagnostic testing, assessments, clinical treatment plans, and on-demand educational content from Mayo Clinic and Harvard Health, through the Bastion Health AI-powered app. With studies showing a 50% reduction in sperm count over the last 40 years, along with 50% of men having prostate issues after the age of 45, men’s health has become a rapidly growing public health issue.

Bastion offers consumer reproductive and prostate telehealth packages starting at $100 and $75, respectively, which includes a 30-minute consultation with a nurse practitioner specializing in men’s health. Men’s health educational content curated and customized from the Mayo Clinic, as well as Harvard Health specifically for Bastion patients, will also be provided in the initial consultation package and will cover topics such as lifestyle, wellness, and nutrition. A deeper clinical assessment, diagnostic testing, and treatment plans with a Bastion Health specialist in urology and reproductive health will be offered initially in the state of Florida and will roll out nationally to include all 50 states in 2022. Proprietary at-home semen analysis diagnostic testing kits will be offered in 2022.

“Men’s healthcare is underserved, behind the times and an upgrade is long overdue,” says Reza Amin, CEO and founder of Bastion Health. “ With our comprehensive platform, we provide an accessible and affordable way for men to proactively take care of their health from the comfort of home and start normalizing the conversation surrounding men’s health.”

Bastion Health was founded in 2020 by Reza Amin with $2.2M in seed funding through the Werth Family Investment Associates.

For more information on Bastion Health, visit http://www.getbastion.com.

About Bastion Health

Bastion Health is the first-ever comprehensive app-based telehealth platform for men’s health specializing in reproductive and prostate health, offering quick and convenient access to urologists and men’s health specialists. Bastion aims to normalize the conversation surrounding men’s health and offers a way for men to proactively take control of their health from the comfort of their own home with convenient consultations, diagnostic testing, assessments, clinical treatment plans, and on-demand educational content, available through the Bastion Health AI-powered app. Bastion Health was founded by Reza Amin and is based in Farmington, CT.

Share article on social media or email:

Dr. Ilana Ressler with her freshly baked Pies for Prevention in 2020.

“I’m honored to once again be involved in the Pies for Prevention program through Sharsheret, a wonderful non-profit organization that supports young women and their families with breast and ovarian cancer,“ says Dr. Ilana Ressler, a reproductive endocrinologist with RMA of Connecticut.

NORWALK, Conn. (PRWEB)
November 02, 2021

For the sixth year in a row, local New Rochelle resident and board-certified Reproductive Endocrinologist from RMA of Connecticut, Dr. Ilana Ressler, will spearhead Pies for Prevention, a charitable program to help promote ovarian cancer awareness. All proceeds from the sale of the pies will benefit Sharsheret, the nonprofit organization that supports young women, men, and their families facing breast and ovarian cancer.

This year marks the 13th annual Sharsheret Thanksgiving Bake Sale, where pies are baked within the community right before Thanksgiving and then distributed to those who have purchased them just in time for the holidays. Pies for Prevention is a program started in 2008 by two sisters, Adeena Sussman and Sharon Wieder, who lost both their mother and grandmother to ovarian cancer. To honor the memories of both women, the sisters decided to memorialize their mother’s and grandmother’s love of baking while raising money for a great cause.

Dr. Ressler, who oversees RMA of Connecticut’s new Harrison office, launched the program in Westchester six years ago, after she was driven to get involved as she continued to meet women faced with breast and ovarian cancer through her job as a reproductive endocrinologist at RMA of Connecticut.

“I’m honored to once again be involved in the Pies for Prevention program through Sharsheret, a wonderful non-profit organization that supports young women and their families with breast and ovarian cancer,“ says Dr. Ilana Ressler, a reproductive endocrinologist with RMA of Connecticut. “We love baking our delicious homemade pies while creating awareness for a good cause. While we do have strict COVID-19 protocols in place, we encourage anyone who is uncomfortable with receiving baked goods this year to make a donation to Sharsheret to support this fantastic organization.”

Homemade pies are $25 and available for order directly on the Sharsheret website. Available flavors include pumpkin, pecan, and their best-selling chocolate chip cookie dough pie, as well as a pumpkin cranberry bread. Gluten-free peanut butter blondies are also available. All ingredients are certified Kosher and Pareve. The deadline to order pies is November 17, 2021.

About Dr. Ilana Ressler

Dr. Ilana Ressler is a Reproductive Endocrinologist, board-certified in both Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility. Dr. Ressler serves as Medical Advisor for Yesh Tikva, which was established to create a Jewish community of support for those experiencing infertility. She also launched the Pies for Prevention program in her Westchester community to benefit Sharsheret, the nonprofit organization supporting Jewish women and families facing breast and ovarian cancer. Dr. Ressler lives in Westchester, New York with her husband and three young children.

About Reproductive Medicine Associates of Connecticut (RMA of Connecticut)

RMA of Connecticut is a leader in fertility care, specializing in a range of infertility treatments. Our assisted reproductive technologies (ART) include intrauterine insemination (IUI), in vitro fertilization (IVF) and pre-implantation genetic screening (PGS). RMA of Connecticut is Fairfield County’s largest fertility clinic and egg donation center, and recently opened a location in Harrison, NY, to better serve Westchester and its surrounding communities. Through RMA of Connecticut’s Integrated Fertility and Wellness program, we offer nutrition counseling, individual and couples psychological counseling, acupuncture and yoga, as well as financing and support services for our patients going through fertility treatment.

Our internationally recognized Gay Parents To Be program at RMA of Connecticut specializes in LGBTQ+ family building. For the last five years, RMA of Connecticut has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign.

Share article on social media or email:

The Sievers Eclipse Bacterial Endotoxins Testing Platform was developed with years of customer input on the challenges faced during bacterial endotoxins testing and the desire to simplify this cumbersome assay.

TORONTO (PRWEB)
November 02, 2021

This webinar will highlight microfluidic technology that not only simplifies bacterial endotoxin testing while fully adhering to global regulations, but also provides an automated and sustainable solution.

A microfluidic system enables users to carry out the same biochemistry with a 1:1 sample to lysate ratio that is performed in traditional 96-well plate assays, but with minimal manual effort, greater consistency and reduced reagent consumption. Users can set up an assay in just nine minutes with replicates and controls.

A full Installation/Operational/Performance Qualification (IOPQ) document is available to support a complete system validation, including 21 CFR Part 11 and data integrity test cases during the operational qualification. Software features are also built in to streamline sample validation. The Sievers Eclipse Bacterial Endotoxins Testing Platform was developed with years of customer input on the challenges faced during bacterial endotoxins testing and the desire to simplify this cumbersome assay.

Register for this webinar to understand how microfluidic technology can drastically simplify endotoxin testing, automate setup and increase throughput, all while maintaining full compliance with USP(85), EP 2.6.14 and data integrity guidelines.

Join experts from SUEZ – Water Technologies & Solutions, Dave Wadsworth, Global Product Manager, Bio-Detection and Brian Short, Global Pharmaceutical Application Specialist, for the live webinar on Wednesday, November 17, 2021 at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit Optimized Endotoxin Testing with Microfluidic Automation.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: